Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:approvedBy |
gptkb:non-small_cell_lung_cancer
gptkb:FDA |
| gptkbp:ATCCode |
L01ED10
|
| gptkbp:CASNumber |
gptkb:1044511-01-3
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:hasInChIKey |
QXJYYZQYKJYFMA-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C21H19FN6O2
|
| gptkbp:hasSMILES |
C1=CC(=CC=C1C2=NC3=CC=CC=C3N2C4=NC(=O)C(=CN4)N)F
|
| https://www.w3.org/2000/01/rdf-schema#label |
1044511-01-3
|
| gptkbp:molecularWeight |
406.42 g/mol
|
| gptkbp:otherName |
gptkb:Lorlatinib
PF-06463922 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:target |
gptkb:ALK
ROS1 |
| gptkbp:usedFor |
antineoplastic agent
|
| gptkbp:bfsParent |
gptkb:benralizumab
gptkb:Benralizumab |
| gptkbp:bfsLayer |
7
|